GKN2 and gastric cancer: Gastrokine-2 expression has been reported to be attenuated in gastric adenocarcinomas (85% of diffuse and 54% intestinal type tumors) (33), whilst in gastric epithelial cells it has been indicated to be significantly upregulated following eradication of Helicobacter pylori, a risk factor for gastric cancer (34).